From O’Dwyer’s PR Blog:

The Vytorin controversy is just icing on a (low cholesterol) cake for those upset with the barrage of drug advertising, and the promotion of “quasi diseases” by big pharmaceutical houses. It’s a safe bet the Congress is going to step up efforts to regulate the marketing practices of prescription drugs.
Bart Stupak, [...]

[Read more →]

Zetia and Vytorin Out—Red Yeast Rice In? (The Daily Green)
Off Label Marketing; J&J Style (PharmaFraud)
Big Pharma Ad Nauseam (Out of My Head)
Big Pharma, Big Money and Cholesterol Confusion (Kate Stone)

Subscribe to the eDrugSearch Blog with Bloglines:

[Read more →]

Double whammy for Big Pharma in Advertising Age today. First, a story headlined “Vytorin Ad Shame Taints Entire Marketing Industry” — an excerpt:
Reports that [as] Merck & Co. and Schering-Plough Corp. kept under wraps for more than a year findings that Vytorin does not deliver results it spent more than $100 million advertising to [...]

[Read more →]

So far in our interview series leading up to the March Health 2.0 conference, we have talked with Scott Shreeve of Crossover Health and Ed Silverman of Pharmalot. Today we share our discussion with Fard Johnmar, founder of Envision Solutions and author of HealthcareVox.
Q: When you write about the Health 2.0 movement, you [...]

[Read more →]

‘Cause Big Pharma sure isn’t coming up with anything. According to PRWeek:
Only twice in the past three decades has the Food and Drug Administration approved fewer than the 18 it gave a thumbs up to in 2007. Compare that to 53 drugs in 1996. Oddly, the FDA said they hadn’t finished tallying numbers [...]

[Read more →]

Big Pharma, “Real” People, Wonkers? (Pharma BlogoSphere)
Frontline’s “The Medicated Child” (The Carlat Psychiatry Blog)
Jarvik — Lipitor spokesperson — “outed” as an unlicensed physician! (Pharma Marketing Blog)
Nigeria Seeks Arrests In Pfizer Trovan Case (Pharmalot)

Subscribe to the eDrugSearch Blog with Bloglines:

[Read more →]

PRWeek writes about “some chatter about a new blog launched to defend the pharmaceutical industry called BigPharmaRealPeople.” Here’s the blog’s alleged story and here’s Ed Silverman’s take on it.
Can you say astroturf? Where’s Montel Williams?

[Read more →]

Just watch this exchange between John McCain and Mitt Romney in the most recent New Hampshire debate over drug reimportation and the power of Big Pharma. It’s clear that if Romney is elected, he’ll do nothing to reform our broken healthcare system.

To say big drug companies are “doing the work of the free market” [...]

[Read more →]

From ScienceDaily:
A new study by two York University researchers estimates the U.S. pharmaceutical industry spends almost twice as much on promotion as it does on research and development, contrary to the industry’s claim.
The researchers’ estimate is based on the systematic collection of data directly from the industry and doctors during 2004, which shows the U.S. [...]

[Read more →]

As a Ron Paul supporter named Vicki rants in his nicely done video:

Big Pharma’s profit margins are the highest of any industry, beating even the widely perceived thievery of the commercial banks.
Big Pharma spends more on lobbying politicians and regulatory bodies than any other industry.
The Medicare Part D plan will hand over [...]

[Read more →]